SK Capital Partners, a private investment firm with a focus on the specialty materials, chemicals and healthcare sectors, has completed a controlling strategic investment in Halo Pharmaceutical, a provider of outsourced development and manufacturing services to the global pharmaceutical industry.   Halo is a technology-focused contract manufacturing business with applications and capabilities in solid, semi-solid and liquid dosage forms, with a particular focus on controlled substances, and has ...